-
Sue, CM, Balasubramaniam, S, Bratkovic, D, Bonifant, C, Christodoulou, J, Coman, D, Crawley, K, Edema‐Hildebrand, F, Ellaway, C, Ghaoui, R, et al. Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations.
Internal Medicine Journal
52(1)
:
110 -120
2021
view publication
-
Van Bergen, NJ, Bell, KM, Carey, K, Gear, R, Massey, S, Murrell, EK, Gallacher, L, Pope, K, Lockhart, PJ, Kornberg, A, et al. Pathogenic variants in nucleoporin TPR (translocated promoter region, nuclear basket protein) cause severe intellectual disability in humans.
Human Molecular Genetics
31(3)
:
362 -375
2021
view publication
-
Sleiman, S, Marshall, AE, Dong, X, Mhanni, A, Alidou-D’Anjou, I, Frosk, P, Marin, SE, Stark, Z, Del Bigio, MR, McBride, A, et al. Compound heterozygous variants in SHQ1 are associated with a spectrum of neurological features, including early-onset dystonia.
Human Molecular Genetics
31(4)
:
ddab247-
2021
view publication
-
Richard, EM, Bakhtiari, S, Marsh, APL, Kaiyrzhanov, R, Wagner, M, Shetty, S, Pagnozzi, A, Nordlie, SM, Guida, BS, Cornejo, P, et al. Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss.
American Journal of Human Genetics
108(10)
:
2006 -2016
2021
view publication
-
Deverell, M, Phu, A, Elliott, EJ, Teutsch, SM, Eslick, GD, Stuart, C, Murray, S, Davis, R, Dalkeith, T, Christodoulou, J, et al. Health‐related out‐of‐pocket expenses for children living with rare diseases ‐ tuberous sclerosis and mitochondrial disorders: A prospective pilot study in Australian families.
Journal of Paediatrics and Child Health
58(4)
:
611 -617
2021
view publication